Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17410539 | 0.87 | POLB (0.56) | POLBKMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL28386472 | 0.86 | POLB (0.65) | POLBKMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL17397904 | 0.80 | POLB (0.53) | POLBKMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL17410737 | 0.79 | POLB (0.58) | POLBKMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL17413598 | 0.78 | POLB (0.51) | POLBSMN1; SMN2NPC1RAB9ACYP1A2 | |
| SCHEMBL17413590 | 0.78 | POLB (0.51) | POLBKMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL20448251 | 0.78 | POLB (0.46) | POLBKMT2ASMN1; SMN2CYP1A2CYP2C19 | |
| SCHEMBL18779295 | 0.78 | POLB (0.59) | POLBKMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL17395276 | 0.77 | POLB (0.47) | POLBKMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL14909043 | 0.77 | POLB (0.55) | POLBKMT2ASMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9988347-B2 | Herbicidally active arylcarboxylic acid amides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-06-05 | — | — | US | disclosed |
| US-9988347-B2 | Herbicidally active arylcarboxylic acid amides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-06-05 | — | — | US | disclosed |
| EP-3160945-B1 | HERBICIDAL ARYLCARBOXYLIC ACID AMIDES | BAYER CROPSCIENCE AG (DE) | 2018-01-31 | — | — | EP | disclosed |
| US-20170158629-A1 | Herbicidally Active Arylcarboxylic Acid Amides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-06-08 | — | — | US | disclosed |
| US-20170158629-A1 | Herbicidally Active Arylcarboxylic Acid Amides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-06-08 | — | — | US | disclosed |
| WO-2016001073-A1 | HERBICIDALLY ACTIVE ARYLCARBOXYLIC ACID AMIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158629-A1 | Herbicidally Active Arylcarboxylic Acid Amides | DDT, AADAC, AOX1 | POLB 2106/4885KMT2A 592/4885SMN1; SMN2 4359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.